Categories
AFNewsNG Logo
Health Special Report

NCDC says new COVID-19 drug, Dexamethasone has not been approved in Nigeria |READ WHY

Thompson Nsisongabasi

Jun 17, 2020

The Nigeria Centre for Disease Control has said that the new COVID-19 drug, Dexamethasone is yet to be approved for use in the treatment of COVID-19 patients in the country.

READ ALSO: I Never Said That - Desmond Elliot Denies To Allegations That He Supported Social Media Regulation Bill (Video)

Scientists in the United Kingdom had hailed the drug, a widely used low-dose steroid, as a major breakthrough after it was found to have considerably reduced the risk of dying from COVID-19.

READ ALSO: SENATOR MAO OHUABUNWA CAMPAIGN RALLY WAVE HITS ABIRIBA, PAYS HOMAGE TO DEPUTY GOVERNOR IN NKPORO

The NCDC in a series of tweets on its official twitter handle, stated: "The Nigeria Centre for Disease Control (NCDC) is aware of recent outcomes from a UK-Government funded clinical trial for COVID-19.

READ ALSO: Why Nigeria Must Declare a State of Emergency on Malaria - Hon. Amobi Ogah Reveals at National Retreat

"The results support the use of Dexamethsaone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation.

READ ALSO: REVEALED: How Common House Rats Can Kill - Shocking Truth Behind Silent Deaths in Nigerian Homes

"Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19. In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by WHO.

READ ALSO: How Nonchalant Attitude at Federal Medical Centre Umuahia Is Turning Accident Victims Into Casualties - Shocking Findings Emerge

"We are aware of ongoing clinical trials conducted by scientists in the UK and will work with our sister agencies to evaluate this emerging data on the use of Dexamethasone. We will inform the general public on outcomes following scientific review and validation.ÔÇØ

Related Stories

""

— Thompson Nsisongabasi

Join the Conversation

Signed in as Member